Positive virtual crossmatch with negative flow crossmatch results in two cases

Transplant Immunology

Volumn 25, Issue 1, 2011, Pages 77-81

  Jacob, Eapen K ^a   De Goey, Steve R ^a   Gandhi, Manish J ^a  

^a Mayo Clinic   (United States)

Author keywords

Antibody to denatured HLA antigen; Donor specific antibody; False positive virtual crossmatch; HLA antibody; Solid phase HLA antibody testing; Virtual crossmatch

Indexed keywords

EPITOPE; HLA ANTIBODY; HLA B ANTIGEN; HLA B44 ANTIGEN; HLA B45 ANTIGEN; HLA DR ANTIGEN; STEROID; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BLOOD GROUP ABO SYSTEM; BRONCHOPNEUMONIA; CARDIAC GRAFT REJECTION; CASE REPORT; CROSS REACTION; DONOR SELECTION; FALSE POSITIVE RESULT; FEMALE; FLOW CYTOMETRY; GENERAL CONDITION DETERIORATION; GRAFT RECIPIENT; HEART LUNG TRANSPLANTATION; HEART RIGHT VENTRICLE FAILURE; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; KIDNEY TRANSPLANTATION; LUNG GRAFT REJECTION; LUNG GRANULOMA; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN DENATURATION; PULMONARY HYPERTENSION; VIRTUAL REALITY;

ADULT; BLOOD PLATELETS; FEMALE; GRAFT REJECTION; HEART-LUNG TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA-B ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TISSUE DONORS;

EID: 79959677710     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.05.007     Document Type: Article

References (14)

1. Rowshani A.T., Bemelman F.J., Lardy N.M., Ten Berge I.J. Humoral immunity in renal transplantation: clinical significance and therapeutic approach. Clin Transplant 2008, 22:689-699.
2. Stewart S., Winters G.L., Fishbein M.C., Tazelaar H.D., Kobashigawa J., Abrams J., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005, 24:1710-1720.
3. Kucirka L.M., Maleszewski J.J., Segev D.L., Halushka M.K. Survey of North American pathologist practices regarding antibody-mediated rejection in cardiac transplant biopsies. Cardiovasc Pathol 2011, 3:132-138.
4. Reed E.F., Demetris A.J., Hammond E., Itescu S., Kobashigawa J.A., Reinsmoen N.L., et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006, 25:153-159.
5. Tan C.D., Sokos G.G., Pidwell D.J., Smedira N.G., Gonzalez-Stawinski G.V., Taylor D.O., et al. Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection. Am J Transplant 2009, 9:2075-2084.
6. Gloor J.M., Winters J.L., Cornell L.D., Fix L.A., DeGoey S.R., Knauer R.M., et al. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant 2010, 10:582-589.
7. Ho E.K., Vlad G., Vasilescu E.R., de la Torre L., Colovai A.I., Burke E., et al. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival. Hum Immunol. 2011, 72:5-10.
8. Sis B., Jhangri G.S., Bunnag S., Allanach K., Kaplan B., Halloran P.F. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009, 9:2312-2323.
9. Ferris J., Cooper S., Roessner K., Hochberg M. Antibodies to denatured type II collagen in rheumatoid arthritis: negative association with IgM rheumatoid factor. J Rheumatol 1990, 17:880-884.
10. Nishida T., Kondo N., Agata H., Fukutomi O., Shinoda S., Suzuki Y., et al. Proliferative responses towards native, heat-denatured and pepsin-treated ovalbumin by peripheral blood mononuclear cells from patients with hen's egg-sensitive atopic dermatitis. Biotherapy 1994, 8:33-40.
11. Morales-Buenrostro L.E., Terasaki P.I., Marino-Vazquez L.A., Lee J.H., El-Awar N., Alberu J. "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 2008, 86:1111-1115.
12. Amico P., Honger G., Steiger J., Schaub S. Utility of the virtual crossmatch in solid organ transplantation. Curr Opin Organ Transplant 2009, 14:656-661.
13. Gandhi M., Ploeger N., DeGoey S. Positive virtual crossmatch (VXM), negative flow crossmatch (FXM): a case of antibody (abs) to denatured antigen (dAg). Hum Immunol 2010, 71:S4.
14. Pereira S., Perkins S., Lee J.H., Shumway W., Lefor W., Lopez-Cepero M., et al. Donor-specific antibody against denatured HLA-A1: Clinically nonsignificant?. Hum Immunol 2011, March 9 (epublished ahead of print).